Relationship Between Cytokine Gene Single Nucleotide Polymorphisms and Symptom Burden and Quality of Life in Lung Cancer Survivors.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 17, p. 4103, doi. 10.1002/cncr.25255
- By:
- Publication type:
- Article
Works by Felten, Sara
Results: 6
1
2
A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 1, p. 39, doi. 10.1007/s00280-007-0443-6
- By:
- Publication type:
- Article
3
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.
- Published in:
- Journal of Neuro-Oncology, 2009, v. 92, n. 2, p. 165
- By:
- Publication type:
- Article
4
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 153, n. 2, p. 435, doi. 10.1007/s10549-015-3545-6
- By:
- Publication type:
- Article
5
Quality of Life: The Assessment, Analysis, and Interpretation of Patient-Reported Outcomes by FAYERS, P. M. and MACHIN, D.
- Published in:
- 2008
- By:
- Publication type:
- Book Review
6
Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 3, p. 473, doi. 10.1007/s10637-009-9381-y
- By:
- Publication type:
- Article